BRG.AU

26.66

-10.08%ā†“

LLC.AU

5.84

-1.52%ā†“

BRG.AU

26.66

-10.08%ā†“

LLC.AU

5.84

-1.52%ā†“

BRG.AU

26.66

-10.08%ā†“

LLC.AU

5.84

-1.52%ā†“

BRG.AU

26.66

-10.08%ā†“

LLC.AU

5.84

-1.52%ā†“

BRG.AU

26.66

-10.08%ā†“

LLC.AU

5.84

-1.52%ā†“

Search

Fisher & Paykel Healthcare Corp Ltd

Open

SectorVastgoed

31.86 0.63

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

31.19

Max

32.29

Belangrijke statistieken

By Trading Economics

Inkomsten

153M

Verkoop

951M

K/W

Sectorgemiddelde

148.143

80.437

EPS

0.26

Dividendrendement

1.26

Winstmarge

16.106

Werknemers

6,978

EBITDA

276M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+20.89% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.26%

5.59%

Volgende Winsten

28 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-3.8B

18B

Vorige openingsprijs

31.23

Vorige sluitingsprijs

31.86

Nieuwssentiment

By Acuity

82%

18%

166 / 192 Rangschikking in Real estate

Fisher & Paykel Healthcare Corp Ltd Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 feb 2025, 21:55 UTC

Marktinformatie

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 feb 2025, 22:06 UTC

Marktinformatie

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28 nov 2024, 21:55 UTC

Marktinformatie

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 nov 2024, 22:39 UTC

Marktinformatie

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2 sep 2024, 23:56 UTC

Marktinformatie

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

30 mei 2024, 00:44 UTC

Marktinformatie
Winsten

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

29 mei 2024, 23:35 UTC

Marktinformatie

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

28 mei 2024, 22:43 UTC

Marktinformatie

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

28 mei 2024, 20:59 UTC

Winsten

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

28 mei 2024, 20:58 UTC

Winsten

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

28 mei 2024, 20:57 UTC

Winsten

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

28 mei 2024, 20:56 UTC

Winsten

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

24 apr 2024, 02:38 UTC

Marktinformatie

F&P Healthcare's Prospects Brighten on Anaesthesia Opportunity -- Market Talk

Peer Vergelijking

Prijswijziging

Fisher & Paykel Healthcare Corp Ltd Prognose

Koersdoel

By TipRanks

20.89% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 37.453Ā AUDĀ  20.89%

Hoogste 42.7Ā AUD

Laagste 35Ā AUD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fisher & Paykel Healthcare Corp Ltd - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

6 ratings

3

Buy

1

Hold

2

Sell

Sentiment

By Acuity

166 / 192 Rangschikking in Vastgoed

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.